www.fdanews.com/articles/62199-sanofi-aventis-france-and-bristol-myers-squibb-company-release-preliminary-injunction-ordered-in-plavix-patent-infringement-case
SANOFI-AVENTIS (FRANCE) AND BRISTOL-MYERS SQUIBB COMPANY RELEASE: PRELIMINARY INJUNCTION ORDERED IN PLAVIX PATENT INFRINGEMENT CASE
September 1, 2006
Sanofi-aventis and Bristol-Myers Squibb (the "companies") today announced that the U.S. District Court for the Southern District of New York has granted a preliminary injunction ordering Apotex Inc. and Apotex Corp. ("Apotex") to halt its sales of a generic version of clopidogrel bisulfate product that competes with PLAVIX. The court,
however, did not order Apotex to recall products already sold/shipped.
BioSpace